Power morcellator for uterine fibroid removal not linked to cancer risk

the ONA take:

According to new findings published in the journal JAMA Oncology, researchers have found that the risk of bits of hidden cancerous tumors spreading throughout the abdomen when a power morcellator is used to remove fibroids in the uterus is low.

Before the U.S. Food and Drug Administration issued a black-box warning on the devices last November that the morcellator could spread and worsen an undetected cancerous uterine tumor, power morcellators were commonly used during minimally invasive surgery to remove uterine fibroids.

Uterine fibroids, which are non-cancerous growths in the uterine wall, are very common, but sometimes need to be removed when they cause pelvic pain and heavy menstrual bleeding. Treatment options include a hysterectomy to remove the uterus or surgery to remove the fibroids.

For the study, researchers identified 42,000 American women who had fibroids removed between 2006 and 2012, 3,200 of which were removed with power morcellators.

Of those, three were found to have uterine cancer, meaning the odds of developing uterine cancer after uterine fibroid removal was about 1 in 1,000 patients compared with 1 in 528 among women whose fibroid removal did not involve the power morcellators. The researchers note that the findings are reassuring.

Study suggests power morcellator for uterine fibroid removal not linked to cancer risk
Risk of bits of hidden cancerous tumors spreading throughout the abdomen when a power morecellator is used to remove fibroids in the uterus is low.
A small power tool that is sometimes used to remove fibroids in the uterus can end up spreading bits of hidden cancerous tumors throughout the abdomen, but a new study suggests the likelihood is low.
READ FULL ARTICLE From Medical Express
Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs